We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 146

The end of times for spon: labelling advertorials appropriately
  • Baker McKenzie
  • United Kingdom
  • December 9 2016

Social media is a cornerstone of modern marketing strategies. Endorsements by celebrities and non-celebrities (particularly bloggers and vloggers who


EMEA Healthcare Industry Group Newsletter - December 2015
  • Baker McKenzie
  • Belgium, European Union, Germany, Italy, Netherlands, Saudi Arabia, Spain, United Arab Emirates, United Kingdom
  • January 25 2016

The Eurasian Economic Union (EAEU) is introducing major new changes in the marketing of pharmaceuticals across its members - which include Russia


CJEU issues ruling on internet browsing technology in the Meltwater case
  • Baker McKenzie
  • European Union, United Kingdom
  • June 5 2014

The Court of Justice of the European Union (CJEU) today issued its decision in the Meltwater Case C-36013, a long-running (5 year) dispute between


High Court grants FAPL site-blocking injunctions against websites providing live streaming of football matches
  • Baker McKenzie
  • United Kingdom
  • August 6 2013

On 16 July Mr Justice Arnold handed down his decision in FAPL v BSkyB in which he granted blocking injunctions against six major UK ISPs in relation


Food & Beverage: Using Social Media to Commercialise Your Brand
  • Baker McKenzie
  • United Kingdom
  • November 7 2016

Using social media to commercialise your brand Social media is becoming a key element of many brands' marketing strategy. It has some great advantages


European pharmaceuticals & healthcare newsletter - April 2015
  • Baker McKenzie
  • United Kingdom, European Union, France, Hungary, Italy
  • April 30 2015

This is a rare example of a major product liability dispute being referred to the European Court of Justice ("ECJ"). The two issues to be decided by


IP and the beauty industry: cosmetic concerns?
  • Baker McKenzie
  • Global, United Kingdom
  • October 21 2015

The world of beauty has well and truly come of age. No longer are women (and increasingly, men), limited to the application of crushed carmine


End of press freedom or advent of effective regulation?
  • Baker McKenzie
  • United Kingdom
  • December 18 2013

While the press regulator, the Press Complaints Commission ("PCC") is still in place for now, its days are numbered. It is widely accepted that the


“If you are not cheating, you are not trying”
  • Baker McKenzie
  • United Kingdom
  • December 18 2013

Integrity, fair play and uncertainty of outcome are fundamental to sport. The thrill is in the highs and lows of watching sporting heroes struggle to


CJEU rules on scope of protection granted to technological protection measures
  • Baker McKenzie
  • European Union, United Kingdom
  • February 20 2014

The CJEU has ruled on the extent to which Article 6 of the Information Society Directive (200129EC) protects technological protection measures